Samsara BioCapital GP, 10% Owner: Neurogene NGNE Buy · Filed 24/11/27

Trade details

Type: Insider buy
Amount: $516,832.68
Shares · price: 20,748 sh · $24.91 a share
Held after: 1,689,105 sh
Stock: Neurogene NGNE
Person: Samsara BioCapital GP10% Owner
Trade date: 24/11/26
Filed: 24/11/27
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +1.2%

Neurogene trades, last 26 weeks

What else happened in Neurogene around then

Filed or reported within 30 days of the trade day · 24/10/27~24/12/26

Samsara BioCapital GP's recent trades

Samsara BioCapital GP10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital GP10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital GP10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital GP10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital GP10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$281K
10,803 sh
$281K
Filed 24/11/27
Traded 24/11/26

Samsara BioCapital GP, 10% Owner — bought $516.8K of Neurogene NGNE · 20,748 sh @ $24.91 | Whalegun